These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2162160)

  • 1. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.
    Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC
    Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; Montelaro RC
    J Virol; 1987 Oct; 61(10):2956-61. PubMed ID: 2442410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.
    Salinovich O; Payne SL; Montelaro RC; Hussain KA; Issel CJ; Schnorr KL
    J Virol; 1986 Jan; 57(1):71-80. PubMed ID: 3001367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
    Howe L; Leroux C; Issel CJ; Montelaro RC
    J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus.
    Montelaro RC; Parekh B; Orrego A; Issel CJ
    J Biol Chem; 1984 Aug; 259(16):10539-44. PubMed ID: 6206055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides.
    Soutullo A; García MI; Bailat A; Racca A; Tonarelli G; Malan Borel I
    Vet Immunol Immunopathol; 2005 Dec; 108(3-4):335-43. PubMed ID: 16105689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; West M; Montelaro RC
    Arch Virol; 1988; 98(3-4):213-24. PubMed ID: 2450529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies.
    Grund CH; Lechman ER; Pezzuolo NA; Issel CJ; Montelaro RC
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():435-42. PubMed ID: 8601778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.
    Craigo JK; Leroux C; Howe L; Steckbeck JD; Cook SJ; Issel CJ; Montelaro RC
    J Gen Virol; 2002 Jun; 83(Pt 6):1353-1359. PubMed ID: 12029150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies.
    Ball JM; Rushlow KE; Issel CJ; Montelaro RC
    J Virol; 1992 Feb; 66(2):732-42. PubMed ID: 1370556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli.
    Payne SL; Rushlow K; Dhruva BR; Issel CJ; Montelaro RC
    Virology; 1989 Oct; 172(2):609-15. PubMed ID: 2552661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of serum neutralizing antibodies induced by transient immune suppression of inapparent carrier ponies infected with a neutralization-resistant equine infectious anemia virus envelope strain.
    Howe L; Craigo JK; Issel CJ; Montelaro RC
    J Gen Virol; 2005 Jan; 86(Pt 1):139-149. PubMed ID: 15604441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus.
    O'Rourke KI; Perryman LE; McGuire TC
    Vet Immunol Immunopathol; 1989 Nov; 23(1-2):41-9. PubMed ID: 2559537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV).
    Rwambo PM; Issel CJ; Hussain KA; Montelaro RC
    Arch Virol; 1990; 111(3-4):275-80. PubMed ID: 1693846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.
    Hammond SA; Li F; McKeon BM; Cook SJ; Issel CJ; Montelaro RC
    J Virol; 2000 Jul; 74(13):5968-81. PubMed ID: 10846078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic variation of equine infectious anemia virus as detected by virus neutralization. Brief report.
    Kono Y
    Arch Virol; 1988; 98(1-2):91-7. PubMed ID: 2829799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.
    Tagmyer TL; Craigo JK; Cook SJ; Issel CJ; Montelaro RC
    J Gen Virol; 2007 Apr; 88(Pt 4):1324-1336. PubMed ID: 17374779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.
    Tallmadge RL; Brindley MA; Salmans J; Mealey RH; Maury W; Carpenter S
    Clin Vaccine Immunol; 2008 Jul; 15(7):1138-40. PubMed ID: 18448619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies.
    Tschetter JR; Byrne KM; Perryman LE; McGuire TC
    Virology; 1997 Apr; 230(2):275-80. PubMed ID: 9143283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
    Hammond SA; Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.